The Shanghai Stock Exchange (SSE) said its Listing Review Committee will convene on June 1 to examine the initial public offering application of Chinese humanoid robot maker Unitree Robotics, a key step toward what could become mainland China's first publicly listed humanoid robotics company.
A fast-tracked STAR Market listing
The hearing will be the committee's 31st listing review meeting of 2026. Unitree's application was formally accepted by the SSE on March 20, 2026, and the company has since completed responses to two rounds of pre-review inquiries from the exchange, reaching the review stage in roughly 73 days. On the day the review date was announced, Unitree also disclosed the draft prospectus for its STAR Market listing.
Inside the fundraising plan
Under the IPO plan, Unitree intends to issue no fewer than 40.45 million new shares and raise about 4.2 billion yuan (roughly $620 million). The proceeds will be directed mainly toward core technology breakthroughs and long-term strategic development, with a particular focus on large AI models for intelligent robotics. According to the company, Unitree posted revenue of 1.699 billion yuan in 2025 and net profit, excluding non-recurring items, of 590 million yuan, with a gross margin of about 60 percent on its core businesses. Some outlets have reported a sharp drop in first-quarter 2026 profit ahead of the review, underscoring the competitive pressure in the embodied-AI market.
China's humanoid IPO race
Unitree, which became one of the world's top humanoid robot sellers, is part of a broader wave of Chinese robotics firms accelerating listing plans. The company previously filed for its Shanghai IPO and has been expanding its consumer reach, including a low-cost humanoid robot sold through Alibaba. Rivals including Leju Robotics and DEEP Robotics have also had IPO applications accepted, while China continues to build out infrastructure for the humanoid sector. The listing would arrive alongside a busy period for technology IPOs that has included new public-market filings across deep-tech.
What comes next
A successful review on June 1 would clear one of the final regulatory hurdles before Unitree can proceed to pricing and a market debut, positioning the Hangzhou-based firm as a bellwether for investor appetite in humanoid robotics. The committee's decision will be closely watched as a signal of how China's capital markets value embodied AI businesses that pair strong revenue growth with thin, volatile profits.
Reporting based on coverage from the Global Times, Caixin Global, and TrendForce.